These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 11231110)

  • 1. Computational modelling of inhibitor binding to human thrombin.
    Ljungberg KB; Marelius J; Musil D; Svensson P; Norden B; Aqvist J
    Eur J Pharm Sci; 2001 Feb; 12(4):441-6. PubMed ID: 11231110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding affinities for sulfonamide inhibitors with human thrombin using Monte Carlo simulations with a linear response method.
    Jones-Hertzog DK; Jorgensen WL
    J Med Chem; 1997 May; 40(10):1539-49. PubMed ID: 9154975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electrostatic steering and ionic tethering in the formation of thrombin-hirudin complexes: the role of the thrombin anion-binding exosite-I.
    Myles T; Le Bonniec BF; Betz A; Stone SR
    Biochemistry; 2001 Apr; 40(16):4972-9. PubMed ID: 11305913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular recognition at the thrombin active site: structure-based design and synthesis of potent and selective thrombin inhibitors and the X-ray crystal structures of two thrombin-inhibitor complexes.
    Obst U; Banner DW; Weber L; Diederich F
    Chem Biol; 1997 Apr; 4(4):287-95. PubMed ID: 9195869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Probing the Dynamics of Clot-Bound Thrombin at Venous Shear Rates.
    Haynes LM; Orfeo T; Mann KG; Everse SJ; Brummel-Ziedins KE
    Biophys J; 2017 Apr; 112(8):1634-1644. PubMed ID: 28445754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Refined 2.3 A X-ray crystal structure of bovine thrombin complexes formed with the benzamidine and arginine-based thrombin inhibitors NAPAP, 4-TAPAP and MQPA. A starting point for improving antithrombotics.
    Brandstetter H; Turk D; Hoeffken HW; Grosse D; Stürzebecher J; Martin PD; Edwards BF; Bode W
    J Mol Biol; 1992 Aug; 226(4):1085-99. PubMed ID: 1518046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of the Differential Activity of Thrombin Inhibitors Using Docking, QSAR, Molecular Dynamics, and MM-GBSA.
    Mena-Ulecia K; Tiznado W; Caballero J
    PLoS One; 2015; 10(11):e0142774. PubMed ID: 26599107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ligand binding cooperativity: Bioisosteric replacement of CO with SO2 among thrombin inhibitors.
    Said AM; Hangauer DG
    Bioorg Med Chem Lett; 2016 Aug; 26(16):3850-4. PubMed ID: 27445170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple binding mode of reversible synthetic thrombin inhibitors. A comparative structural analysis.
    Pavone V; De Simone G; Nastri F; Galdiero S; Staiano N; Lombardi A; Pedone C
    Biol Chem; 1998; 379(8-9):987-1006. PubMed ID: 9792431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enzyme flexibility, solvent and 'weak' interactions characterize thrombin-ligand interactions: implications for drug design.
    Engh RA; Brandstetter H; Sucher G; Eichinger A; Baumann U; Bode W; Huber R; Poll T; Rudolph R; von der Saal W
    Structure; 1996 Nov; 4(11):1353-62. PubMed ID: 8939759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-based design and synthesis of novel thrombin inhibitors based on phosphinic peptide mimetics.
    Li M; Lin Z; Johnson ME
    Bioorg Med Chem Lett; 1999 Jul; 9(14):1957-62. PubMed ID: 10450962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of thrombin with antithrombin, heparin cofactor II, and protein C inhibitor.
    Whinna HC; Church FC
    J Protein Chem; 1993 Dec; 12(6):677-88. PubMed ID: 8136018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions of some commonly used drugs with human α-thrombin.
    Nair DG; Narayanan SP; Chittalakkottu S
    J Biomol Struct Dyn; 2015; 33(5):1008-15. PubMed ID: 24819365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure of a retro-binding peptide inhibitor complexed with human alpha-thrombin.
    Tabernero L; Chang CY; Ohringer SL; Lau WF; Iwanowicz EJ; Han WC; Wang TC; Seiler SM; Roberts DG; Sack JS
    J Mol Biol; 1995 Feb; 246(1):14-20. PubMed ID: 7853394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A fluorine scan of the phenylamidinium needle of tricyclic thrombin inhibitors: effects of fluorine substitution on pKa and binding affinity and evidence for intermolecular C-F...CN interactions.
    Olsen J; Seiler P; Wagner B; Fischer H; Tschopp T; Obst-Sander U; Banner DW; Kansy M; Müller K; Diederich F
    Org Biomol Chem; 2004 May; 2(9):1339-52. PubMed ID: 15105924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A model for the binding of low molecular weight inhibitors to the active site of thrombin.
    Allen MC; Cockcroft XL; Gruetter MG; Priestle JP
    J Comput Aided Mol Des; 1999 Nov; 13(6):579-88. PubMed ID: 10584216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitor binding to thrombin: x-ray crystallographic studies.
    Banner DW; Hadváry P
    Adv Exp Med Biol; 1993; 340():27-33. PubMed ID: 8154341
    [No Abstract]   [Full Text] [Related]  

  • 18. Regulation of thrombin activity--pharmacologic and structural aspects.
    Tanaka KA; Levy JH
    Hematol Oncol Clin North Am; 2007 Feb; 21(1):33-50. PubMed ID: 17258117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural and Functional Characterization of Hirudin P6 Derived Novel Bivalent Thrombin Inhibitors - Studying the Effect of Linker Length and Glycosylation on Their Function.
    Shabareesh P; Kaur KJ
    Chem Biol Drug Des; 2016 Jul; 88(1):129-41. PubMed ID: 26850929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, Synthesis, and Biological Evaluation of Dabigatran Etexilate Mimics, a Novel Class of Thrombin Inhibitors.
    Wang S; Dai P; Xu Y; Chen Q; Zhu Q; Gong G
    Arch Pharm (Weinheim); 2015 Aug; 348(8):595-605. PubMed ID: 26120827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.